Skip to main content
. 2014 Aug 29;5(19):8947–8958. doi: 10.18632/oncotarget.2407

Figure 5. Plerixafor modulates surface CXCR7 expression.

Figure 5

(A) Baseline surface CXCR7 expression as measured by flow cytometry. Surface CXCR7 expression after treatment with plerixafor for (B) 4 hours and (C) 24 hours.